文献速递糖尿病

ERK1对小鼠胰岛β细胞功能并非必需,但为葡萄糖诱导的MSK1和CREB完全激活所必需

ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB.
PubMed 文献 · Diabetologia · 2017-07-18

研究利用ERK1敲除小鼠及药理手段,探讨ERK1与ERK2在胰岛β细胞中的独立作用。结果显示同时抑制ERK1/2使葡萄糖诱导胰岛素第一时相快速瞬时峰值降低40%(p<0.01),但ERK1不参与该过程;ERK1为葡萄糖诱导MSK1和CREB完全激活所必需。

要点

  • 同时抑制ERK1与ERK2使葡萄糖诱导胰岛素第一时相快速瞬时峰值降低40%(p<0.01),ERK1不参与此过程。
  • Erk1-/-小鼠β细胞中MSK1和CREB活性低于Erk1+/+小鼠(p<0.01),仅重新表达ERK1而非过表达ERK2可恢复其磷酸化。
  • 4月龄Erk1-/-小鼠胰岛面积占比略高于Erk1+/+小鼠(0.74%±0.03% vs 0.62%±0.04%,p<0.05)。

核心结论

  • ERK1和ERK2在β细胞中扮演特定角色,ERK2不能总是代偿ERK1的缺失。
  • Erk1-/-小鼠缺乏明确表型,表明ERK1在正常条件下并非必需。

研究设计与样本

  • 研究使用ERK1(亦称Mapk3)敲除小鼠(Erk1-/-小鼠)及药理学方法评估ERK1和ERK2在β细胞中的独立作用。
  • 在胰岛中测定NAD(P)H、游离胞质Ca2+浓度和胰岛素分泌。
  • 采用全内反射荧光显微镜监测ERK1和ERK2的质膜下转位及活性。
  • 通过蛋白质印迹和/或免疫细胞化学评估ERK1/2、MSK1和CREB的激活。
  • 从胰腺切片测定胰岛质量。

主要发现

  • 葡萄糖诱导ERK1和ERK2快速质膜下募集。
  • 同时抑制ERK1和ERK2使葡萄糖诱导胰岛素分泌第一时相快速瞬时峰值降低40%(p<0.01),但ERK1似乎不参与该过程。
  • Erk1-/-小鼠β细胞中MSK1和CREB活性低于Erk1+/+小鼠β细胞(p<0.01),仅重新表达ERK1而非过表达ERK2可恢复其磷酸化。
  • 4月龄Erk1-/-小鼠胰岛面积占比略高于Erk1+/+小鼠(均值±标准误:0.74%±0.03% vs 0.62%±0.04%,p<0.05)。
  • 10月龄Erk1-/-小鼠较Erk1+/+小鼠更不易发生年龄相关胰腺胰岛周围炎(浸润胰岛均值±标准误:7.51%±1.34% vs 2.03%±0.51%,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Insufficient insulin secretion from pancreatic beta cells, which is associated with a decrease in beta cell mass, is a characteristic of type 2 diabetes. Extracellular signal-related kinase 1 and 2 (ERK1/2) inhibition in beta cells has been reported to affect insulin secretion, gene transcription and survival, although whether ERK1 and ERK2 play distinct roles is unknown. The aim of this study was to assess the individual roles of ERK1 and ERK2 in beta cells using ERK1 (also known as Mapk3)-knockout mice (Erk1 -/- mice) and pharmacological approaches. METHODS: NAD(P)H, free cytosolic Ca2+ concentration and insulin secretion were determined in islets. ERK1 and ERK2 subplasmalemmal translocation and activity was monitored using total internal reflection fluorescence microscopy. ERK1/2, mitogen and stress-activated kinase1 (MSK1) and cAMP-responsive element-binding protein (CREB) activation were evaluated by western blot and/or immunocytochemistry. The islet mass was determined from pancreatic sections. RESULTS: Glucose induced rapid subplasmalemmal recruitment of ERK1 and ERK2. When both ERK1 and ERK2 were inhibited simultaneously, the rapid transient peak of the first phase of glucose-induced insulin secretion was reduced by 40% (p < 0.01), although ERK1 did not appear to be involved in this process. By contrast, ERK1 was required for glucose-induced full activation of several targets involved in beta cell survival; MSK1 and CREB were less active in Erk1 -/- mouse beta cells (p < 0.01) compared with Erk1 +/+ mouse beta cells, and their phosphorylation could only be restored when ERK1 was re-expressed and not when ERK2 was overexpressed. Finally, the islet mass of Erk1 -/- mice was slightly increased in young animals (4-month-old mice) vs Erk1 +/+ mice (section occupied by islets [mean ± SEM]: 0.74% ± 0.03% vs 0.62% ± 0.04%; p < 0.05), while older mice (10 months old) were less prone to age-associated pancreatic peri-insulitis (infiltrated islets [mean ± SEM]: 7.51% ± 1.34% vs 2.03% ± 0.51%; p < 0.001). CONCLUSIONS/INTERPRETATION: ERK1 and ERK2 play specific roles in beta cells. ERK2 cannot always compensate for the lack of ERK1 but the absence of a clear-cut phenotype in Erk1 -/- mice shows that ERK1 is dispensable in normal conditions.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Leduc M, Richard J, Costes S, et al. ERK1 is dispensable for mouse pancreatic beta cell function but is necessary for glucose-induced full activation of MSK1 and CREB. Diabetologia. 2017. PMID: 28721437. doi:10.1007/s00125-017-4356-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。